Key result
Percutaneous intervention with stenting is emerging as a promising therapeutic option for unprotected left main coronary artery stenosis in carefully selected patients.
This review summarizes the emerging role and technical considerations of percutaneous coronary intervention for unprotected left main coronary artery stenosis in carefully selected patients.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open the need for randomized trials to define its role.
Advances in percutaneous intervention make it possible to expand the use of angioplasty to multiple and complex coronary artery lesions. Unfortunately, unprotected left main coronary artery (LMCA) stenosis has been regarded as a contraindication of percutaneous intervention because of its potential risk of early cardiac death and poor late clinical outcomes. However, LMCA stenosis is an attractive target for percutaneous intervention because of its larger caliber, short lesion length, and lack of tortuosity. Recently, stenting of unprotected LMCA stenoses has been reported with promising results in carefully selected patients. It now can be considered as a therapeutic option of unprotected LMCA stenoses in selected centers. This article summarizes the current status, technical considerations, and future directions of percutaneous intervention in the treatment of unprotected LMCA stenoses.
No takes yet. Share an insight, caveat, or question.
Seung‐Jung Park (1998) conducted a review in Unprotected left main coronary artery (LMCA) stenosis. Percutaneous intervention (stenting) was evaluated. Percutaneous intervention with stenting is emerging as a promising therapeutic option for unprotected left main coronary artery stenosis in carefully selected patients.
Synapse has enriched 10 related papers. Consider them for comparative context: